Drug Information

Drug General Information
Drug ID
D02MUA
Former ID
DIB010716
Drug Name
PF-06439535
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524593]
Company
Pfizer
Target and Pathway
Target(s) VEGF ligand Target Info [550401]
References
Ref 524593ClinicalTrials.gov (NCT02031991) A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01). U.S. National Institutes of Health.
Ref 550401National Cancer Institute Drug Dictionary (drug id 43234).